CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.
Saved in:
| Title: | CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors. |
|---|---|
| Authors: | Uzhachenko RV; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., González Ochoa S; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Kanagasabai T; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Rajakaruna H; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States., Thounaojam MC; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; Department of Biomedical Sciences, Meharry Medical College School of Graduate Studies, Nashville, TN, United States., de Aquino MTP; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Rana T; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Costa L; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Terekhov A; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Hofmeister WH; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Sayers TJ; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States., Boyer C; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France., Ivanova AV; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Goodwin JS; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Schmitt-Verhulst AM; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France., Shanker A; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States.; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States.; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Sep 22; Vol. 16, pp. 1593913. Date of Electronic Publication: 2025 Sep 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1593913 |
